A.D. Flapan
Impact in
- Pharmacology top 5%
- Apelin-related biomedical research
-
- Nuclear Receptors and Signaling
Papers in
-
- Heart Failure Treatment and Management 5
- Cardiac electrophysiology and arrhythmias 4
- Atrial Fibrillation Management and Outcomes 3
- Cardiac Valve Diseases and Treatments 3
- Renin-Angiotensin System Studies 2
- Cardiac pacing and defibrillation studies 2
- Surgery 2
- Co-authors
- John Mathews (1 shared paper)Martin A. Denvir (1 shared paper)David E. Newby (1 shared paper)Neil R. Johnston (1 shared paper)Alan G. Japp (1 shared paper)Gareth Barnes (1 shared paper)Ian L. Megson (1 shared paper)Nicholas L. Cruden (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (3 papers)European Heart Journal (2 papers)Heart (2 papers)The Journal of the Royal College of Physicians of Edinburgh (1 paper)Journal of Hypertension (1 paper)
- Partner nations
- United KingdomBangladeshPortugal
In The Last Decade
A.D. Flapan
14 papers receiving 321 citations
Peers
Comparison fields: 5 of 41
- Pharmacology 246
- Cellular and Molecular Neuroscience 135
- Surgery 231
- Cardiology and Cardiovascular Medicine 99
- Endocrinology, Diabetes and Metabolism 63
Countries citing papers authored by A.D. Flapan
This map shows the geographic impact of A.D. Flapan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.D. Flapan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.D. Flapan more than expected).
Fields of papers citing papers by A.D. Flapan
This network shows the impact of papers produced by A.D. Flapan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.D. Flapan. The network helps show where A.D. Flapan may publish in the future.
Co-authors
The 25 scholars most cited alongside A.D. Flapan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 274 | |
| 2 | 1991 | 9 | |
| 3 | 1991 | 9 | |
| 4 | 1992 | 9 | |
| 5 | 1994 | 8 | |
| 6 | 1992 | 6 | |
| 7 | 1992 | 4 | |
| 8 | 1992 | 3 | |
| 9 | 1987 | 3 | |
| 10 | 1988 | 3 | |
| 11 | 1991 | 2 | |
| 12 | 1991 | 2 | |
| 13 | 1992 | 2 | |
| 14 | 2008 | 1 |
About A.D. Flapan
A.D. Flapan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology, Epidemiology and Nephrology, having authored 14 papers that have together received 335 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (5 papers), Cardiac electrophysiology and arrhythmias (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Cardiac Valve Diseases and Treatments (3 papers), Renin-Angiotensin System Studies (2 papers), Cardiac pacing and defibrillation studies (2 papers), Diet, Metabolism, and Disease (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Pharmacology (246 citations), Cellular and Molecular Neuroscience (135 citations), Surgery (231 citations), Cardiology and Cardiovascular Medicine (99 citations) and Endocrinology, Diabetes and Metabolism (63 citations). A.D. Flapan has collaborated with scholars based in United Kingdom, Bangladesh and Portugal. Frequent co-authors include John Mathews, Martin A. Denvir, David E. Newby, Neil R. Johnston, Alan G. Japp, Gareth Barnes, Ian L. Megson, Nicholas L. Cruden, J W Adamson and Brent C. Williams. Their work appears in journals such as European Journal of Clinical Pharmacology, European Heart Journal, Heart, The Journal of the Royal College of Physicians of Edinburgh and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.